
Hikma Secures Rights to a Portfolio of Takeda Brands for the MENA Region
Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, has agreed with Takeda Pharmaceuticals International AG (Takeda) to acquire the rights to 17 brands currently licensed to Hikma for select territories in the Middle East and North Africa (MENA) region. Through a number of licensing contracts, the latest of which